by EmpathiCSubstanceS | Nov 7, 2020 | Iboga, LSD
sychedelic pharmaceutical company MindMed is set to conduct a novel Phase 1 clinical trial exploring the subjective effects of combining LSD with MDMA. The primary goal of the prospective study is to investigate whether MDMA, a drug known to induce feelings of...
by EmpathiCSubstanceS | Nov 7, 2020 | Iboga, LSD
Neuropsychologists at The Netherlands’ Maastricht University and their colleagues report that microdoses of LSD can increase mood and cognition. In their double-blind, placebo-controlled study of 24 participants, the researchers administered doses of 0-20...
by EmpathiCSubstanceS | Nov 7, 2020 | Iboga, LSD
MindMed Is Collaborating on a Phase 2 Clinical Trial of LSD For Cluster Headaches with University Hospital Basel’s Liechti Lab BASEL, Switzerland, June 8, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMEDOTCQB: MMEDF), is supporting and...
by EmpathiCSubstanceS | Nov 7, 2020 | Cannabis Marijuana
Can worker-owned cooperatives and crowdfunding create a better cannabis industry for both consumers and businesses? This was the question posed by two Massachusetts cannabis veterans Sonia Erika and Ross Bradshaw during the recent Students for Sensible Drug...
by EmpathiCSubstanceS | Nov 7, 2020 | Psychedelic Medicine
In central Florida, not far from Disney World and the Magic Kingdom, there’s another magical kind of kingdom of sorts, promising its visitors a bit of that old Walt Disney adage: “It’s kind of fun to do the impossible.” But you won’t find giant mice and roller...
